achalasia is a well- defined esophageal motor disorder. graded pneumatic dilation using rigiflex ballon is one of the therapeutic modalities that had not been evaluated in a large long-term study. we aimed at evaluating long-term efficacy of graded rigiflex pneumatic dilation in the treatment of achalasia. symptomatic patients with achalasia who had been referred to our center were consecutivel...

BACKGROUND Pneumatic balloon dilation is a popular method of treating patients with achalasia cardia. It may be useful to know the factors that predict response to this treatment. AIM To determine predictors of outcome following pneumatic balloon dilation in patients with achalasia cardia. METHODS Records of 62 patients who had undergone pneumatic dilation using Rigiflex balloon dilators (B...

This study evaluated the efficacy and safety of endoscopic pneumatic balloon dilatation as the initial treatment for achalasia of the cardia. 15 patients with achalasia underwent a total of 19 dilatations using the new polyethylene dilator (Microvasive Rigiflex Balloon Dilator) over the last 6 years. An overall treatment success rate of 93% was achieved. 11 patients (73.3%) have not required a ...

PATIENT Female, 82 FINAL DIAGNOSIS: Achalasia Symptoms: Nocturnal regurgtation • weight loss MEDICATION - Clinical Procedure: Esophageal stenting Specialty: Gastroenterology • Hepatology Objective: Unusual or unexpected effect of treatment. BACKGROUND Pneumatic dilatation is one of the most effective methods for treating achalasia. Esophageal perforation is the most serious complication aft...

among the therapeutic options for achalasia are pneumatic dilatation (pd), an appropriate long-term therapy, and botulinum toxin injection (bt) that is a relatively short-term therapy. this study aimed to compare therapeutic effect of repetitive pneumatic dilation with a combined method (botulinum toxin injection and pneumatic dilation) in a group of achalasia patients who are low responder to ...

background achalasia is the most recognized motor disorder of the esophagus.because it is an uncommon disease, most studies have reviewed small numbers of patients. here, we report demographic, clinical features and treatment outcomes in 700 achalasia patients. methods in all patients, diagnosis was established based on clinical, radiological, endoscopic and manometric criteria. a questionnaire...

background: achalasia is the most recognized esophageal motor disorder with an unknown etiology. symptoms rather than physical findings are hallmarks of the disease. modalilies for treatment include pharmacologic, botulinum toxin injection, pneumatic dilation and surgery. materials and methods: to review the diagnostic and therapeutic options currently available for achalasia. a medline search ...

BACKGROUND/AIMS Pneumatic dilatation of the oesophagus is a well established treatment for achalasia. Oesophageal perforation is the most serious complication that occurs in 2% to 6% of cases. The aim of this retrospective survey was to identify predictive risk factors for perforation in a consecutive series of 218 patients with achalasia. METHODS Between 1983 and 1993, 270 pneumatic dilatati...

We read with interest the article by Eckardt et al regarding the long term results of pneumatic dilatation in achalasia (Gut 2004;53:629–33). Fifty four patients were followed up for a median of 14 years after a single pneumatic dilatation using the Browne-McHardy dilator. Five and 10 year remission rates were 40% and 36%, respectively, and repeated dilatations only mildly improved the clinical...